These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 17261417

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intricacies of bevacizumab-induced toxicities and their management.
    Gressett SM, Shah SR.
    Ann Pharmacother; 2009 Mar; 43(3):490-501. PubMed ID: 19261963
    [Abstract] [Full Text] [Related]

  • 6. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies.
    Shih T, Lindley C.
    Clin Ther; 2006 Nov; 28(11):1779-802. PubMed ID: 17212999
    [Abstract] [Full Text] [Related]

  • 7. Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer.
    Sandler AB, Johnson DH, Herbst RS.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 2):4258s-4262s. PubMed ID: 15217970
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. "Spontaneous," delayed colon and rectal anastomotic complications associated with bevacizumab therapy.
    August DA, Serrano D, Poplin E.
    J Surg Oncol; 2008 Feb 01; 97(2):180-5. PubMed ID: 18095268
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Managing patients treated with bevacizumab combination therapy.
    Gordon MS, Cunningham D.
    Oncology; 2005 Feb 01; 69 Suppl 3():25-33. PubMed ID: 16301833
    [Abstract] [Full Text] [Related]

  • 13. Crescentic glomerulonephritis associated with vascular endothelial growth factor (VEGF) inhibitor and bisphosphonate administration.
    Stylianou K, Lioudaki E, Papadimitraki E, Kokologiannakis G, Kroustalakis N, Liotsi C, Giannakakis K, Georgoulias V, Daphnis E.
    Nephrol Dial Transplant; 2011 May 01; 26(5):1742-5. PubMed ID: 21382992
    [Abstract] [Full Text] [Related]

  • 14. Anti-VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome.
    Yılmaz S, Özçakar ZB, Taktak A, Kiremitçi S, Ensari A, Dinçaslan H, Yalçınkaya F.
    Pediatr Nephrol; 2016 Jun 01; 31(6):1029-32. PubMed ID: 26928310
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Routine proteinuria monitoring for bevacizumab in patients with gynecologic malignancies.
    Lee CS, Alwan LM, Sun X, McLean KA, Urban RR.
    J Oncol Pharm Pract; 2016 Dec 01; 22(6):771-776. PubMed ID: 26447100
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.